UBS Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-115,482
Closed -$5.97M 10575
2022
Q3
$5.97M Buy
115,482
+21,145
+22% +$1.09M ﹤0.01% 1599
2022
Q2
$2.34M Sell
94,337
-73,833
-44% -$1.83M ﹤0.01% 2291
2022
Q1
$4.22M Buy
168,170
+156,793
+1,378% +$3.93M ﹤0.01% 2065
2021
Q4
$414K Sell
11,377
-97,897
-90% -$3.56M ﹤0.01% 4118
2021
Q3
$1.87M Buy
109,274
+90,544
+483% +$1.55M ﹤0.01% 2799
2021
Q2
$251K Sell
18,730
-40,368
-68% -$541K ﹤0.01% 4186
2021
Q1
$3.03M Sell
59,098
-71,430
-55% -$3.66M ﹤0.01% 2403
2020
Q4
$8.08M Buy
130,528
+129,931
+21,764% +$8.05M ﹤0.01% 1514
2020
Q3
$33K Sell
597
-142,508
-100% -$7.88M ﹤0.01% 5083
2020
Q2
$8.23M Sell
143,105
-757,622
-84% -$43.6M ﹤0.01% 1302
2020
Q1
$36.2M Buy
900,727
+75,135
+9% +$3.02M 0.02% 541
2019
Q4
$32.7M Sell
825,592
-176,024
-18% -$6.96M 0.01% 794
2019
Q3
$6.79M Buy
1,001,616
+605,004
+153% +$4.1M ﹤0.01% 1630
2019
Q2
$3.69M Buy
396,612
+390,976
+6,937% +$3.64M ﹤0.01% 2034
2019
Q1
$78K Sell
5,636
-10,298
-65% -$143K ﹤0.01% 4461
2018
Q4
$174K Buy
15,934
+9,844
+162% +$107K ﹤0.01% 4221
2018
Q3
$77K Buy
6,090
+4,032
+196% +$51K ﹤0.01% 4934
2018
Q2
$27K Buy
2,058
+808
+65% +$10.6K ﹤0.01% 5568
2018
Q1
$17K Sell
1,250
-1,015
-45% -$13.8K ﹤0.01% 5647
2017
Q4
$13K Buy
2,265
+1,646
+266% +$9.45K ﹤0.01% 5907
2017
Q3
$5K Buy
+619
New +$5K ﹤0.01% 6329
2017
Q1
Sell
-16,561
Closed -$123K 6915
2016
Q4
$123K Buy
16,561
+16,539
+75,177% +$123K ﹤0.01% 4266
2016
Q3
$0 Sell
22
-1,114
-98% ﹤0.01% 6923
2016
Q2
$5K Buy
+1,136
New +$5K ﹤0.01% 6247
2016
Q1
Sell
-2,118
Closed -$17K 6953
2015
Q4
$17K Sell
2,118
-636
-23% -$5.11K ﹤0.01% 5696
2015
Q3
$17K Buy
2,754
+2,524
+1,097% +$15.6K ﹤0.01% 5584
2015
Q2
$2K Sell
230
-1,271
-85% -$11.1K ﹤0.01% 6574
2015
Q1
$11K Sell
1,501
-777
-34% -$5.69K ﹤0.01% 5820
2014
Q4
$16K Buy
+2,278
New +$16K ﹤0.01% 5748